These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3994127)

  • 41. Efficacy of a nonviable culture-derived Babesia bovis vaccine.
    Kuttler KL; Levy MG; James MA; Ristic M
    Am J Vet Res; 1982 Feb; 43(2):281-4. PubMed ID: 7046534
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bovine anaplasmosis: in utero transmission and the immunologic significance of ingested colostral antibodies.
    Zaugg JL; Kuttler KL
    Am J Vet Res; 1984 Mar; 45(3):440-3. PubMed ID: 6711971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vaccination of cattle against experimentally induced thromboembolic meningoencephalitis with a Haemophilus somnus bacterin.
    Stephens LR; Little PB; Humphrey JD; Wilkie BN; Barnum DA
    Am J Vet Res; 1982 Aug; 43(8):1339-42. PubMed ID: 7103217
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The mechanism of protective immunity in bovine anaplasmosis.
    Carson CA; Ristic M
    Proc Annu Meet U S Anim Health Assoc; 1977; (81):69-71. PubMed ID: 286365
    [No Abstract]   [Full Text] [Related]  

  • 45. Infectivity virulence and immunogenicity of Anaplasma centrale live blood vaccine.
    Potgieter FT; Van Rensburg L
    Onderstepoort J Vet Res; 1983 Mar; 50(1):29-31. PubMed ID: 6348636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparisons of the complement-fixation, indirect fluorescent antibody, and card agglutination tests for the diagnosis of bovine anaplasmosis.
    Gonzalez EF; Long RF; Todorovic RA
    Am J Vet Res; 1978 Sep; 39(9):1538-41. PubMed ID: 358874
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunity in bovine anaplasmosis after elimination of anaplasma marginale infections with imidocarb.
    Roby TO; Amerault TE; Mazzola V; Rose JE; Ilemobade A
    Am J Vet Res; 1974 Jul; 35(7):993-5. PubMed ID: 4842856
    [No Abstract]   [Full Text] [Related]  

  • 48. Laboratory and field trials with an attenuated Anaplasma marginale vaccine.
    Welter CJ; Ristic M
    Proc Annu Meet U S Anim Health Assoc; 1969; 73():122-30. PubMed ID: 5278170
    [No Abstract]   [Full Text] [Related]  

  • 49. Recrudescence of Anaplasma marginale induced by immunosuppression with cyclophosphamide.
    Corrier DE; Wagner GG; Adams LG
    Am J Vet Res; 1981 Jan; 42(1):19-21. PubMed ID: 7224313
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Field observations on the duration of immunity in cattle after vaccination against Anaplasma and Babesia species.
    Tjornehoj K; Lawrence JA; Whiteland AP; Kafuwa PT
    Onderstepoort J Vet Res; 1996 Mar; 63(1):1-5. PubMed ID: 8848296
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peripheral blood lymphocyte proliferative responses in cattle infected with or vaccinated against Anaplasma marginale.
    Gale KR; Gartside MG; Dimmock CM; Zakrzewski H; Leatch G
    Parasitol Res; 1996; 82(6):551-62. PubMed ID: 8832738
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum neutralizing antibody response and protection against experimentally induced liver abscesses in steers vaccinated with Fusobacterium necrophorum.
    Saginala S; Nagaraja TG; Tan ZL; Lechtenberg KF; Chengappa MM; Kemp KE; Hine PM
    Am J Vet Res; 1996 Apr; 57(4):483-8. PubMed ID: 8712511
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of 4 serological tests in the detection of humoral antibodies to anaplasmosis in cattle.
    Wilson AJ; Trueman KF; Spinks G; McSorley AF
    Aust Vet J; 1978 Aug; 54(8):383-6. PubMed ID: 363118
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of purified Anaplasma marginale initial bodies as a vaccine against anaplasmosis.
    Montenegro-James S; James MA; Benitez MT; Leon E; Baek BK; Guillen AT
    Parasitol Res; 1991; 77(2):93-101. PubMed ID: 2027888
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anaplasma marginale: lack of cross-protection between strains that share MSP1a variable region and MSP4.
    Ocampo Espinoza V; Vázquez JE; Aguilar MD; Ortiz MA; Alarcón GJ; Rodríguez SD
    Vet Microbiol; 2006 Apr; 114(1-2):34-40. PubMed ID: 16386388
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of vaccination of calves against induced Haemophilus somnus pneumonia.
    Groom SC; Little PB
    Am J Vet Res; 1988 Jun; 49(6):793-800. PubMed ID: 3400916
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Observations on the use of Anaplasma centrale for immunization of cattle against anaplasmosis in Zimbabwe.
    Turton JA; Katsande TC; Matingo MB; Jorgensen WK; Ushewokunze-Obatolu U; Dalgliesh RJ
    Onderstepoort J Vet Res; 1998 Jun; 65(2):81-6. PubMed ID: 9741051
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of breed of cattle on innate resistance to infection with Anaplasma marginale transmitted by Boophilus microplus.
    Bock RE; Kingston TG; De Vos AJ
    Aust Vet J; 1999 Nov; 77(11):748-51. PubMed ID: 10685172
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Humoral immune response of cattle with anaplasmosis].
    Vŭlchovski R; Vŭlchovski Ia; Zurliĭski P
    Vet Med Nauki; 1980; 17(3):75-7. PubMed ID: 7222462
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular and serological detection of A. centrale- and A. marginale-infected cattle grazing within an endemic area.
    Molad T; Mazuz ML; Fleiderovitz L; Fish L; Savitsky I; Krigel Y; Leibovitz B; Molloy J; Jongejan F; Shkap V
    Vet Microbiol; 2006 Mar; 113(1-2):55-62. PubMed ID: 16300909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.